kt 6149 has been researched along with Body Weight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furumoto, H; Hara, T; Ikegami, J; Ishii, A; Suzuki, K; Takaba, K; Takahashi, J | 1 |
| Asami, N; Inaba, M; Morimoto, M; Sudo, Y; Tsuruo, T | 1 |
2 other study(ies) available for kt 6149 and Body Weight
| Article | Year |
|---|---|
Inhibitory effects of subcutaneous dexamethasone treatment on rat pulmonary toxicity of KW-2149, a new mitomycin C analogue.
Topics: Animals; Antibiotics, Antineoplastic; Basement Membrane; Body Weight; Clinical Chemistry Tests; Dexamethasone; Disease Models, Animal; Drug Interactions; Dyspnea; Endothelium; Glucocorticoids; Hematologic Tests; Injections, Subcutaneous; Lung; Male; Mitomycins; Organ Size; Pleural Effusion; Rats; Rats, Sprague-Dawley | 2000 |
Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Humans; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation | 1990 |